CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-06 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +29,325 | $3.80 | $111K | 86,728 |
| 2025-08-06 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −29,325 | $32.55 | $955K | 57,403 |
| 2025-08-06 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −29,325 | 36,542 | ||
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +38,928 | $10.36 | $403K | 88,843 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +30,444 | $12.97 | $395K | 119,287 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +32,710 | $11.10 | $363K | 151,997 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +25,896 | $11.97 | $310K | 177,893 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,636 | $10.76 | $114K | 188,529 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −138,064 | $33.20 | $4.6M | 50,465 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −550 | $33.90 | $19K | 49,915 |
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −38,928 | 0 | ||
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −30,444 | 16,694 | ||
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −32,710 | 32,710 | ||
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −25,896 | 39,524 | ||
| 2025-08-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −10,636 | 31,908 | ||
| 2025-08-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +18,889 | $22.89 | $432K | 45,898 |
| 2025-08-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −18,889 | $32.89 | $621K | 27,009 |
| 2025-08-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −18,889 | 2,036 | ||
| 2025-08-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +17,000 | $15.52 | $264K | 50,041 |
| 2025-08-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −17,000 | $32.35 | $550K | 33,041 |
Page 28 of 74 · 1,467 trades